$PBIO The details of the PCT-enhanced MMS workflow
Post# of 46475
![Avatar](/images/ProfileImages/754971288_289_stock market picture.jpg)
About RedShiftBio.
RedShiftBio® is a provider of innovative analytical instrumentation for the research, development and manufacture of protein therapeutic drugs. The company has developed a powerful new analytical technique, Microfluidic Modulation Spectroscopy (MMS) that enables direct probing of the biophysical structure of proteins. The patented MMS technology provides comprehensive secondary structure information across five key measurements, in a single automated analysis, replacing the requirement to run samples on multiple instruments. For further information, please visit www.redshiftbio.com/ or email info@redshiftbio.com.
https://www.otcmarkets.com/stock/PBIO/news/Pr...?id=259357
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)